Multiple sclerosis patients' response to COVID-19 pandemic and vaccination in Egypt.

Adel Hassanein Elsayed GadSandra Mohamed AhmedMostafa Yahya Abdelmohsen GaradahAhmed Dahshan

Published in: The Egyptian journal of neurology, psychiatry and neurosurgery (2022)

Prevalence of COVID-19 infection and severity of infection were equal to general population. Risk of relapse is low either with infection or vaccination. No severe adverse events were reported after vaccination.

Keyphrases

multiple sclerosis
end stage renal disease
newly diagnosed
chronic kidney disease
prognostic factors
risk factors
peritoneal dialysis
white matter
free survival